Literature DB >> 25287926

Mycobacterium tuberculosis strains lacking surface lipid phthiocerol dimycocerosate are susceptible to killing by an early innate host response.

Tracey A Day1, John E Mittler2, Molly R Nixon1, Cullen Thompson1, Maurine D Miner1, Mark J Hickey1, Reiling P Liao1, Jennifer M Pang1, Dmitry M Shayakhmetov3, David R Sherman4.   

Abstract

The innate immune response plays an important but unknown role in host defense against Mycobacterium tuberculosis. To define the function of innate immunity during tuberculosis, we evaluated M. tuberculosis replication dynamics during murine infection. Our data show that the early pulmonary innate immune response limits M. tuberculosis replication in a MyD88-dependent manner. Strikingly, we found that little M. tuberculosis cell death occurs during the first 2 weeks of infection. In contrast, M. tuberculosis cells deficient in the surface lipid phthiocerol dimycocerosate (PDIM) exhibited significant death rates, and consequently, total bacterial numbers were reduced. Host restriction of PDIM-deficient M. tuberculosis was not alleviated by the absence of interferon gamma (IFN-γ), inducible nitric oxide synthase (iNOS), or the phagocyte oxidase subunit p47. Taken together, these data indicate that PDIM protects M. tuberculosis from an early innate host response that is independent of IFN-γ, reactive nitrogen intermediates, and reactive oxygen species. By employing a pathogen replication tracking tool to evaluate M. tuberculosis replication and death during infection, we identify both host and pathogen factors affecting the outcome of infection.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25287926      PMCID: PMC4249296          DOI: 10.1128/IAI.01340-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis.

Authors:  W Peters; H M Scott; H F Chambers; J L Flynn; I F Charo; J D Ernst
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis.

Authors:  Dana G Mordue; L David Sibley
Journal:  J Leukoc Biol       Date:  2003-09-12       Impact factor: 4.962

3.  Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways.

Authors:  Philipp Henneke; Osamu Takeuchi; Richard Malley; Egil Lien; Robin R Ingalls; Mason W Freeman; Tanya Mayadas; Victor Nizet; Shizuo Akira; Dennis L Kasper; Douglas T Golenbock
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

4.  Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals.

Authors:  Carl G Feng; Charles A Scanga; Carmen M Collazo-Custodio; Allen W Cheever; Sara Hieny; Patricia Caspar; Alan Sher
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

5.  Isolation of Mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation.

Authors:  Kevin Pethe; Dana L Swenson; Sylvie Alonso; Jennifer Anderson; Carren Wang; David G Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-31       Impact factor: 11.205

6.  Production of phthiocerol dimycocerosates protects Mycobacterium tuberculosis from the cidal activity of reactive nitrogen intermediates produced by macrophages and modulates the early immune response to infection.

Authors:  Cécile Rousseau; Nathalie Winter; Elisabeth Pivert; Yann Bordat; Olivier Neyrolles; Patrick Avé; Michel Huerre; Brigitte Gicquel; Mary Jackson
Journal:  Cell Microbiol       Date:  2004-03       Impact factor: 3.715

7.  Lipids of putative relevance to virulence in Mycobacterium tuberculosis: correlation of virulence with elaboration of sulfatides and strongly acidic lipids.

Authors:  M B Goren; O Brokl; W B Schaefer
Journal:  Infect Immun       Date:  1974-01       Impact factor: 3.441

8.  Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation.

Authors:  Kaeryn N Lewis; Reiling Liao; Kristi M Guinn; Mark J Hickey; Sherilyn Smith; Marcel A Behr; David R Sherman
Journal:  J Infect Dis       Date:  2002-12-02       Impact factor: 5.226

9.  Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids.

Authors:  C J Cambier; Kevin K Takaki; Ryan P Larson; Rafael E Hernandez; David M Tobin; Kevin B Urdahl; Christine L Cosma; Lalita Ramakrishnan
Journal:  Nature       Date:  2013-12-15       Impact factor: 49.962

10.  CD8+ T cells accumulate in the lungs of Mycobacterium tuberculosis-infected Kb-/-Db-/- mice, but provide minimal protection.

Authors:  Kevin B Urdahl; Denny Liggitt; Michael J Bevan
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

View more
  19 in total

1.  Comparative metabolic profiling of mce1 operon mutant vs wild-type Mycobacterium tuberculosis strains.

Authors:  Adriano Queiroz; Daniel Medina-Cleghorn; Olivera Marjanovic; Daniel K Nomura; Lee W Riley
Journal:  Pathog Dis       Date:  2015-08-28       Impact factor: 3.166

2.  A Nonsense Mutation in Mycobacterium marinum That Is Suppressible by a Novel Mechanism.

Authors:  Emily A Williams; Felix Mba Medie; Rachel E Bosserman; Benjamin K Johnson; Cristal Reyna; Micah J Ferrell; Matthew M Champion; Robert B Abramovitch; Patricia A Champion
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

3.  A Screen for Protein-Protein Interactions in Live Mycobacteria Reveals a Functional Link between the Virulence-Associated Lipid Transporter LprG and the Mycolyltransferase Antigen 85A.

Authors:  Megan H Touchette; Erik R Van Vlack; Lu Bai; Jia Kim; Armand B Cognetta; Mary L Previti; Keriann M Backus; Dwight W Martin; Benjamin F Cravatt; Jessica C Seeliger
Journal:  ACS Infect Dis       Date:  2017-03-21       Impact factor: 5.084

4.  Designing of a Chimeric Vaccine Using EIS (Rv2416c) Protein Against Mycobacterium tuberculosis H37Rv: an Immunoinformatics Approach.

Authors:  R Logesh; V Lavanya; Shazia Jamal; Neesar Ahmed
Journal:  Appl Biochem Biotechnol       Date:  2021-11-24       Impact factor: 2.926

5.  F420H2 Is Required for Phthiocerol Dimycocerosate Synthesis in Mycobacteria.

Authors:  Endang Purwantini; Lacy Daniels; Biswarup Mukhopadhyay
Journal:  J Bacteriol       Date:  2016-07-13       Impact factor: 3.490

6.  Diversity of Mycobacterium tuberculosis across Evolutionary Scales.

Authors:  Mary B O'Neill; Tatum D Mortimer; Caitlin S Pepperell
Journal:  PLoS Pathog       Date:  2015-11-12       Impact factor: 6.823

7.  The conical shape of DIM lipids promotes Mycobacterium tuberculosis infection of macrophages.

Authors:  Jacques Augenstreich; Evert Haanappel; Guillaume Ferré; Georges Czaplicki; Franck Jolibois; Nicolas Destainville; Christophe Guilhot; Alain Milon; Catherine Astarie-Dequeker; Matthieu Chavent
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-22       Impact factor: 11.205

Review 8.  Cholesterol and fatty acids grease the wheels of Mycobacterium tuberculosis pathogenesis.

Authors:  Kaley M Wilburn; Rachael A Fieweger; Brian C VanderVen
Journal:  Pathog Dis       Date:  2018-03-01       Impact factor: 3.166

9.  Phthiocerol dimycocerosates promote access to the cytosol and intracellular burden of Mycobacterium tuberculosis in lymphatic endothelial cells.

Authors:  Thomas R Lerner; Christophe J Queval; Antony Fearns; Urska Repnik; Gareth Griffiths; Maximiliano G Gutierrez
Journal:  BMC Biol       Date:  2018-01-04       Impact factor: 7.431

Review 10.  When Dicty Met Myco, a (Not So) Romantic Story about One Amoeba and Its Intracellular Pathogen.

Authors:  Elena Cardenal-Muñoz; Caroline Barisch; Louise H Lefrançois; Ana T López-Jiménez; Thierry Soldati
Journal:  Front Cell Infect Microbiol       Date:  2018-01-09       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.